LEXX / Lexaria Bioscience Corp. - Net Long/Short Value

Lexaria Bioscience Corp.
US ˙ NasdaqCM ˙ US52886N4060

LEXX / Lexaria Bioscience Corp. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Royal Bank Of Canada
Vanguard Fiduciary Trust Co
BCV Asset Management Inc.
State Street Corp
SBI Securities Co., Ltd.
Renaissance Technologies Llc
Invenomic Capital Management LP
Citadel Advisors Llc
Toronto Dominion Bank
Hrt Financial Lp
Vanguard Group Inc
Bank Of Montreal /can/
Federation des caisses Desjardins du Quebec
XTX Topco Ltd
BlackRock, Inc.
Byrne Asset Management LLC
Farther Finance Advisors, LLC
Geode Capital Management, Llc
Citigroup Inc
Krilogy Financial LLC
Tower Research Capital LLC (TRC)
Northern Trust Corp
UBS Group AG
Advisor Group Holdings, Inc.
Vanguard Global Advisers, LLC
Morgan Stanley
Vontobel Holding Ltd.
Vanguard Capital Management Llc
Gables Capital Management Inc.
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista